Grantclosed🌐 United StatesRFA-CA-25-006

Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)

National Institutes of Health

Details?

Posted: Dec 31, 2024
Response deadline: Dec 9, 2025, 12:00 AM UTC
Type: Grant
Category: 93.394
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: RFA-CA-25-006

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
United States · Dec 31, 2024
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
United States · Dec 31, 2024
NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
United States · Oct 18, 2024
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
United States · Oct 12, 2021
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
United States · Nov 4, 2019
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
United States · Dec 16, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.